SHARES in medical diagnostics specialist Omega Diagnostics surged nearly 10 per cent after it won approval for its ground-breaking HIV testing kit to be used in Nigeria, writes Scott Wright.
Alva-based Omega said Nigeria’s Federal Ministry of Health (MOH) has given the green light for the Visitect CD4 350 test to be deployed following evaluation of the product in six geopolitical zones.
CD4 tests are used to assess the progression of HIV and prioritise patients at risk of opportunistic infections.
While usually carried out in laboratory conditions, the Omega kit can be used to provide care to people living in areas with few resources, such as rural territory.
Omega said the MOH approval means the product will become the first rapid and instrument-free CD4 test to be implemented in Nigeria to care for people living with HIV.
Chief executive Colin King said: “I am pleased that our test has been approved for use in Nigeria which was one of our key strategic aims and allows our unique point-of-care test to make a real difference to people living with HIV in Nigeria.”
The development comes after Omega received an initial order in Nigeria for 250,000 tests from its distribution partner.
Shares closed up 1.4p, or 9.49%, at 16.15p.